Cyren Ltd: Cyren Announces Third Quarter 2019 Financial Results

Year-to-date revenue up 9% despite slight revenue decline during quarter

MCLEAN, VA / ACCESSWIRE / November 13, 2019 / Cyren (NASDAQ:CYRN) today announced its third quarter 2019 financial results for the period ending September 30, 2019.

During the third quarter, Cyren reported quarterly revenues of $9.5 million, compared to $9.6 million during the third quarter of 2018. For the first three quarters of 2019, year-to-date revenues were $28.9 million, which represents a 9% annual increase over the first three quarters of 2018.

GAAP net loss for the quarter was $3.5 million, compared to $4.4 million during the third quarter of 2018. Year-to-date, net loss declined to $12.7 million compared to a net loss of $13.8 million over the same period a year ago.

"Our top priority is driving more aggressive growth and we are refining our strategy to take advantage of the market opportunities we see," said Brett Jackson, CEO of Cyren. "Our team has made very good progress over the past several months and are now very focused on execution. We expect to begin seeing the benefits from our key initiatives emerging over the next several quarters."

Third Quarter 2019 Financial Highlights:

Revenues for the third quarter of 2019 were $9.5 million, compared to $9.6 million during the third quarter of 2018.
GAAP net loss for the third quarter of 2019 was $3.5 million, compared to a net loss of $4.4 million in the third quarter of 2018.
GAAP loss per basic and diluted share for the third quarter of 2019 was $0.06, compared to a loss of $0.08 per basic and diluted share for the third quarter of 2018.
Non-GAAP net loss for the third quarter of 2019 was $3.5 million, compared to a Non-GAAP net loss of $3.3 million for the third quarter of 2018.
Non-GAAP loss per basic and diluted share was $0.06 for the third quarter of 2019, compared to a Non-GAAP loss of $0.06 per share in third quarter of 2018.
Cash used in operating activities during the third quarter of 2019 was $1.7 million, compared to operating cash usage of $2.6 million during the third quarter of 2018.
Net cash flow for the third quarter of 2019 was negative $2.9 million, compared to negative $3.1 million during the third quarter of 2018.
Cash balance as of September 30, 2019, was $9.5 million, compared to $17.6 million as of December 31, 2018. This does not include the proceeds of the Rights Offering detailed below.

For information regarding the non-GAAP financial measures discussed in this release, please see "Use of Non-GAAP Financial Measures" and "Reconciliation of Selected GAAP Measures to Non-GAAP Measures."

Rights Offering:

During the third quarter, Cyren announced a Rights Offering to shareholders of record as of September 25. Right holders were entitled to purchase one ordinary share at a subscription price of $1.73 per share. The Rights Offering closed on November 6, 2019 and generated approximately $8 million of gross proceeds to Cyren, which is not reflected in the September 30, 2019 cash balance. Pursuant to the Rights Offering, Cyren issued a total of 4,635,584 ordinary shares at $1.73 per share, including 4,624,277 shares issued to the company's majority shareholder, WP XII Investments B.V., an entity controlled by funds affiliated with Warburg Pincus. After the offering, Cyren now has 59,319,391 shares outstanding.

Financial Results Conference Call:

The company will host a conference call at 10 a.m. Eastern Time (5 p.m. Israel Time) on Wednesday, November 13, 2019 to discuss third quarter results.

U.S. Dial-in Number: 1-877-407-0312
Israel Dial-in Number: 1-80-940-6247
International Dial-in Number: 1-201-389-0899

The call will be simultaneously webcast live on the investor relations section of Cyren's website at https://ir.cyren.com, or by using the following link: https://webcasts.eqs.com/cyren20191113/.

For those unable to participate in the live conference call, a replay will be available until November 27, 2019. To access the replay, the U.S. dial in number is 1-877-660-6853 and the non-U.S. dial in number is 1-201-612-7415. Callers will be prompted for replay conference ID number 13696074. An archived version of the webcast will also be available on the investor relations section of the company's website at https://ir.cyren.com/events.

About Cyren:

More than 1.3 billion users around the world rely on Cyren's 100% cloud security solutions to protect them against cyber attacks and data loss every day. Powered by the world's largest security cloud, Cyren (NASDAQ: CYRN) delivers fast time-to-protection with award-winning email security, cloud sandboxing and DNS filtering services for business, and threat intelligence solutions for service providers and security vendors like Microsoft, Google and Check Point. Learn more at www.cyren.com.

Blog: http://blog.cyren.com
Facebook: www.facebook.com/CyrenWeb
LinkedIn: www.linkedin.com/company/cyren
Twitter: www.twitter.com/CyrenInc

Use of Non-GAAP Financial Measures:

Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: stock-based compensation expenses, amortization of acquired intangible assets, and deferred taxes related to acquisitions, adjustments to earn-out obligations, and capitalization of technology. The purpose of such adjustments is to give an indication of the company's performance exclusive of non-cash charges and other items that are considered by management to be outside of the company's core operating results. The company's non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read only in conjunction with the company's consolidated financial statements prepared in accordance with GAAP.

Company management regularly uses supplemental non-GAAP financial measures internally to understand, manage and evaluate the business and make operating decisions.

These non-GAAP measures are among the primary factors management uses in planning for and forecasting future periods. The company believes this adjustment is useful to investors as a measure of the ongoing performance of the business. The company believes these non-GAAP financial measures provide consistent and comparable measures to help investors understand the company's current and future operating cash flow performance. These non-GAAP financial measures may differ materially from the non-GAAP financial measures used by other companies. Reconciliation between results on a GAAP and non-GAAP basis is provided in a table immediately following the Consolidated Statements of Income. The presentation of this non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Management uses both GAAP and non-GAAP measures when evaluating the business internally and therefore felt it important to make these non-GAAP adjustments available to investors.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. For example, statements in the future tense, and statements including words such as "expect," "plan," "estimate," "anticipate," or "believe" are forward-looking statements. These statements are based on information available at the time of the press release and the company assumes no obligation to update any of them. The statements in this press release are not guarantees of future performance and actual results could differ materially from current expectations as a result of numerous factors, including our CEO transition, business conditions and growth or deterioration in the internet security market, technological developments, products offered by competitors, availability of qualified staff, and technological difficulties and resource constraints encountered in developing new products, as well as those risks described in the company's publicly filed reports, which are available through www.sec.gov.

CYREN LTD. 
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands of U.S. dollars, except per share amounts) 

 
Three months ended
 
 
Nine months ended
 

 
September 30
 
 
September 30
 

 
2019
 
 
2018
 
 
2019
 
 
2018
 

 
Unaudited
 
 
Unaudited
 
 
Unaudited
 
 
Unaudited
 

Revenues

 
$ 
9,496
 
 
$ 
9,562
 
 
$ 
28,862
 
 
$ 
26,388
 

Cost of revenues

 
 
3,712
 
 
 
3,670
 
 
 
11,501
 
 
 
10,684
 

Gross profit

 
 
5,784
 
 
 
5,892
 
 
 
17,361
 
 
 
15,704
 

Operating expenses:

Research and development, net

 
 
3,516
 
 
 
4,336
 
 
 
11,990
 
 
 
11,355
 

Sales and marketing

 
 
3,027
 
 
 
3,931
 
 
 
10,473
 
 
 
12,133
 

General and administrative

 
 
2,484
 
 
 
2,166
 
 
 
7,314
 
 
 
6,151
 

Total operating expenses

 
 
9,027
 
 
 
10,433
 
 
 
29,777
 
 
 
29,639
 

Operating loss

 
 
(3,243
)
 
 
(4,541
)
 
 
(12,416
)
 
 
(13,935
)

Other income (expense), net

 
 
(3
)
 
 
–
 
 
 
262
 
 
 
(17
)

Financial income (expense), net

 
 
(321
)
 
 
7
 
 
 
(642
)
 
 
(91
)

Loss before taxes

 
 
(3,567
)
 
 
(4,534
)
 
 
(12,796
)
 
 
(14,043
)

Tax benefit

 
 
37
 
 
 
107
 
 
 
117
 
 
 
201
 

Net loss

 
$ 
(3,530)
 
 
$ 
(4,427)
 
 
$ 
(12,679)
 
 
$ 
(13,842)
 

Loss per share – basic and diluted

 
$ 
(0.06
)
 
$ 
(0.08
)
 
$ 
(0.23
)
 
$ 
(0.26
)

Weighted average number of shares outstanding:

Basic and Diluted

 
 
54,554
 
 
 
53,679
 
 
 
54,389
 
 
 
53,503
 

CYREN LTD.
RECONCILIATION OF SELECTED GAAP MEASURES TO NON-GAAP MEASURES
(in thousands of U.S.dollars, except per share amounts)

 
Three months ended
 
 
Nine months ended
 

 
September 30
 
 
September 30
 

 
2019
 
 
2018
 
 
2019
 
 
2018
 

 
Unaudited
 
 
Unaudited
 
 
Unaudited
 
 
Unaudited
 

GAAP gross profit

 
$ 
5,784
 
 
$ 
5,892
 
 
$ 
17,361
 
 
$ 
15,704
 

GAAP gross margin

 
 
61
%
 
 
62
%
 
 
60
%
 
 
60
%

Plus:

Stock-based compensation

 
 
36
 
 
 
48
 
 
 
98
 
 
 
124
 

Amortization of intangible assets

 
 
758
 
 
 
907
 
 
 
2,364
 
 
 
2,692
 

Non-GAAP gross profit

 
 
6,578
 
 
 
6,847
 
 
 
19,823
 
 
 
18,520
 

Non-GAAP gross margin

 
 
69
%
 
 
72
%
 
 
69
%
 
 
70
%

GAAP operating loss

 
 
(3,243
)
 
 
(4,541
)
 
 
(12,416
)
 
 
(13,935
)

Plus:

Stock-based compensation

 
 
419
 
 
 
358
 
 
 
1,002
 
 
 
1,031
 

Amortization of intangible assets

 
 
883
 
 
 
1,060
 
 
 
2,736
 
 
 
3,157
 

Capitalization of technology

 
 
(1,118
)
 
 
(242
)
 
 
(2,510
)
 
 
(1,886
)

Non-GAAP operating loss

 
 
(3,059
)
 
 
(3,365
)
 
 
(11,188
)
 
 
(11,633
)

GAAP net loss

 
 
(3,530
)
 
 
(4,427
)
 
 
(12,679
)
 
 
(13,842
)

Plus:

Stock-based compensation expense

 
 
419
 
 
 
358
 
 
 
1,002
 
 
 
1,031
 

Intangible amortization expense

 
 
883
 
 
 
1,060
 
 
 
2,736
 
 
 
3,157
 

Adjustment to earn-out liabilities

 
 
–
 
 
 
23
 
 
 
–
 
 
 
75
 

Amortization of deferred tax assets

 
 
(55
)
 
 
(62
)
 
 
(170
)
 
 
(188
)

Gain from an earn-out liability settlement

 
 
–
 
 
 
–
 
 
 
(256
)
 
 
–
 

Capitalization of technology

 
 
(1,169
)
 
 
(242
)
 
 
(2,627
)
 
 
(1,886
)

Non-GAAP net loss

 
$ 
(3,452
)
 
$ 
(3,290
)
 
$ 
(11,994
)
 
$ 
(11,653
)

Numerator for non-GAAP EPS calculation

 
$ 
(3,452
)
 
$ 
(3,290
)
 
$ 
(11,994
)
 
$ 
(11,653
)

Non-GAAP net loss per share

 
$ 
(0.06
)
 
$ 
(0.06
)
 
$ 
(0.22
)
 
$ 
(0.22
)

GAAP weighted-average shares used to

compute net loss per share

 
 
54,554
 
 
 
53,679
 
 
 
54,389
 
 
 
53,503
 

CYREN LTD.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands of U.S. dollars)

 
September 30
 
 
December 31
 

 
2019
 
 
2018
 

 
Unaudited
 
 
Audited
 

Assets

Current Assets:

Cash and cash equivalents

 
$ 
9,546
 
 
$ 
17,571
 

Trade receivables, net

 
 
3,499
 
 
 
3,658
 

Deferred commissions

 
 
930
 
 
 
887
 

Prepaid expenses and other receivables

 
 
1,329
 
 
 
778
 

Total current assets

 
 
15,304
 
 
 
22,894
 

Long-term deferred commissions

 
 
1,646
 
 
 
1,880
 

Long-term lease deposits

 
 
782
 
 
 
821
 

Operating lease right-of-use assets

 
 
8,974
 
 
 
–
 

Severance pay fund

 
 
610
 
 
 
503
 

Property and equipment, net

 
 
4,437
 
 
 
4,608
 

Intangible assets, net

 
 
8,667
 
 
 
8,802
 

Goodwill

 
 
19,904
 
 
 
20,519
 

Total long-term assets

 
 
45,020
 
 
 
37,133
 

Total assets

 
$ 
60,324
 
 
$ 
60,027
 

Liabilities and Shareholders' Equity

Current Liabilities:

Trade payables

 
$ 
1,402
 
 
$ 
1,668
 

Employees and payroll accruals

 
 
3,690
 
 
 
3,959
 

Accrued expenses and other liabilities

 
 
1,421
 
 
 
910
 

Operating lease liabilities

 
 
1,298
 
 
 
–
 

Earn-out consideration

 
 
–
 
 
 
2,926
 

Deferred revenues

 
 
9,270
 
 
 
5,773
 

Total current liabilities

 
 
17,081
 
 
 
15,236
 

Deferred revenues

 
 
2,944
 
 
 
503
 

Convertible notes

 
 
10,000
 
 
 
10,000
 

Long-term operating lease liabilities

 
 
7,993
 
 
 
–
 

Deferred tax liability

 
 
912
 
 
 
1,130
 

Accrued severance pay

 
 
778
 
 
 
598
 

Other liabilities

 
 
337
 
 
 
700
 

Total long-term liabilities

 
 
22,964
 
 
 
12,931
 

Shareholders' equity

 
 
20,279
 
 
 
31,860
 

Total liabilities and shareholders' equity

 
$ 
60,324
 
 
$ 
60,027
 

CYREN LTD. 
CONDENSED CONSOLIDATED CASH FLOW DATA
(in thousands of U.S. dollars)

 
Three months ended
 
 
Nine months ended
 

 
September 30
 
 
September 30
 

 
2019
 
 
2018
 
 
2019
 
 
2018
 

Cash flows from operating activities:

 
Unaudited
 
 
Unaudited
 
 
Unaudited
 
 
Unaudited
 

Net loss

 
$ 
(3,530
)
 
$ 
(4,427
)
 
$ 
(12,679
)
 
$ 
(13,842
)

Loss on disposal of property and equipment

 
 
–
 
 
 
–
 
 
 
1
 
 
 
14
 

Depreciation

 
 
484
 
 
 
438
 
 
 
1,420
 
 
 
1,434
 

Stock-based compensation

 
 
419
 
 
 
358
 
 
 
1,002
 
 
 
1,031
 

Amortization of intangible assets

 
 
885
 
 
 
1,060
 
 
 
2,736
 
 
 
3,157
 

Amortization of deferred commissions

 
 
(297
)
 
 
445
 
 
 
(909
)
 
 
1,005
 

Amortization of operating lease right-of-use assets

 
 
338
 
 
 
–
 
 
 
1,051
 
 
 
–
 

Interest on convertible notes

 
 
142
 
 
 
–
 
 
 
424
 
 
 
–
 

Other expenses (income) related to the earn-out consideration

 
 
–
 
 
 
23
 
 
 
(257
)
 
 
75
 

Deferred taxes, net

 
 
(55
)
 
 
(57
)
 
 
(182
)
 
 
(152
)

Changes in assets and liabilities:

Trade receivables

 
 
(509
)
 
 
(607
)
 
 
196
 
 
 
(292
)

Prepaid expenses and other receivables

 
 
168
 
 
 
306
 
 
 
(607
)
 
 
(392
)

Deferred commissions

 
 
353
 
 
 
(954
)
 
 
1,101
 
 
 
(1,797
)

Change in long-term lease deposits

 
 
2
 
 
 
5
 
 
 
25
 
 
 
(110
)

Trade payables

 
 
559
 
 
 
375
 
 
 
(264
)
 
 
306
 

Employees and payroll accruals, accrued expenses and other liabilities

 
 
39
 
 
 
346
 
 
 
(185
)
 
 
677
 

Deferred revenues

 
 
(357
)
 
 
110
 
 
 
5,997
 
 
 
3,040
 

Accrued severance pay, net

 
 
5
 
 
 
21
 
 
 
73
 
 
 
(120
)

Operating lease liabilities

 
 
(342
)
 
 
–
 
 
 
(1,075
)
 
 
–
 

Other long-term liabilities

 
 
(15
)
 
 
1
 
 
 
(126
)
 
 
71
 

Net cash provided by (used in) operating activities

 
 
(1,711
)
 
 
(2,557
)
 
 
(2,258
)
 
 
(5,895
)

Cash flows from investing activities:

Proceeds from sale of property and equipment

 
 
1
 
 
 
–
 
 
 
1
 
 
 
–
 

Capitalization of technology, net of grants received

 
 
(1,027
)
 
 
(384
)
 
 
(2,462
)
 
 
(1,844
)

Purchase of property and equipment

 
 
(309
)
 
 
(1,156
)
 
 
(1,259
)
 
 
(2,989
)

Net cash used in investing activities

 
 
(1,335
)
 
 
(1,540
)
 
 
(3,720
)
 
 
(4,833
)

Cash flows from financing activities:

Payment of earnout liability

 
 
–
 
 
 
–
 
 
 
(2,680
)
 
 
(604
)

Proceeds from options exercised

 
 
231
 
 
 
984
 
 
 
743
 
 
 
1,276
 

Net cash provided by (used in) financing activities

 
 
231
 
 
 
984
 
 
 
(1,937
)
 
 
672
 

Effect of exchange rate changes on cash

 
 
(76
)
 
 
12
 
 
 
(124
)
 
 
(39
)

Increase (decrease) in cash, cash equivalents and restricted cash

 
 
(2,891)
 
 
 
(3,101)
 
 
 
(8,039)
 
 
 
(10,095)
 

Cash, cash equivalents and restricted cash at the beginning of the period

 
 
13,008
 
 
 
17,234
 
 
 
18,156
 
 
 
24,228
 

Cash, cash equivalents and restricted cash at the end of the period

 
$ 
10,117
 
 
$ 
14,133
 
 
$ 
10,117
 
 
$ 
14,133
 

Reconciliation of cash, cash equivalents and restricted cash as shown in the consolidated statements of cash flow:

Cash and cash equivalents

 
$ 
9,546
 
 
$ 
13,527
 
 
$ 
9,546
 
 
$ 
13,527
 

Restricted cash included in long-term restricted lease deposits

 
 
571
 
 
 
606
 
 
 
571
 
 
 
606
 

Total cash, cash equivalents and restricted cash

 
$ 
10,117
 
 
$ 
14,133
 
 
$ 
10,117
 
 
$ 
14,133
 

Company Contact
Mike Myshrall, CFO
Cyren
+1.703.760.3320
mike.myshrall@cyren.com

SOURCE: Cyren Ltd

ReleaseID: 566311